Miglustat
treatment for a rare or metabolic disease
Nothing to addWhat this medicine is for
Miglustat is a medicine in the category "treatment for a rare or metabolic disease". This medicine addresses a specific rare or metabolic disease, in a specialised setting.
For Miglustat, in practice: Treats certain storage diseases. Its prescription and administration fall within a specialised, often hospital, setting.
Under which brands it is found
Miglustat is part of the composition of about 7 presentations listed in France. It is found under several brand names and as generics.
- Miglustat
- Miglustat Accord
- Miglustat Bluefish
- Miglustat Dipharma
- Opfolda
- Yargesa
- Zavesca
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
For Miglustat, we offer no supplement. No nutritional supplementation is seriously justified as an addition to this treatment, and we would rather write that than invent a need. Our range is limited to five classes of everyday medicines for which a targeted intake makes sense; outside of those, we do not sell for the sake of selling, and that is what gives weight to our five products.
Talk about it in the community
A space to share among people who are affected: the early days, the habits built up over the years, what each person has found to live better with it. Shared experiences, nothing medical.
Related molecules
To explore in the « Other areas » family and its neighbours.